Literature DB >> 24837875

Evidence-based outcomes for mesh-based surgery for pelvic organ prolapse.

Jayadev R Mettu1, Marc Colaco, Gopal H Badlani.   

Abstract

PURPOSE OF REVIEW: In light of all the recent controversy regarding the use of synthetic mesh for pelvic organ prolapse, we did a retrospective review of the evidence-based outcomes and complications for its use. RECENT
FINDINGS: A total of 18 of the most recent studies in the last 5 years were selected. Studies selected were prospective randomized or quasi-randomized controlled trials that included surgical operations for pelvic organ prolapse for this review. Additionally, Cochrane review and meta-analysis of outcomes and complication were also analyzed. In terms of outcomes, the definition of successful surgery is currently being debated. Synthetic mesh provides superior anatomical and subjective cure rates compared with native tissue repair. Success rates varied greatly depending on the nature of prolapse and surgical approach. Furthermore, recurrence rates for mesh-based surgery are significantly lower than that for native tissue repair. The main unique complication of mesh is exposure and was reported in a mean of 11.4% of patients, with 6.8% of patients requiring surgical partial excision of mesh.
SUMMARY: Mesh significantly improves anatomical outcomes with sacrocolpopexy and vaginal repair. Mesh does create the unique complication which can be reduced with training and proper patient selection. Further development of better materials is vital rather than reverting to tissue-based repair. Ultimately, the decision to use mesh should be based upon a patient's personal goals and preferences after an informed conversation with her physician.

Entities:  

Mesh:

Year:  2014        PMID: 24837875     DOI: 10.1097/MOU.0000000000000063

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  7 in total

1.  Transvaginal repair of stage III-IV cystocele using a lightweight mesh: safety and 36-month outcome.

Authors:  Renaud de Tayrac; Majid Brouziyne; Gérard Priou; Guy Devoldère; Gérard Marie; Joël Renaudie
Journal:  Int Urogynecol J       Date:  2015-03-03       Impact factor: 2.894

Review 2.  Comparison of synthetic mesh erosion and chronic pain rates after surgery for pelvic organ prolapse and stress urinary incontinence: a systematic review.

Authors:  Eoin MacCraith; Eoghan M Cunnane; Michael Joyce; James C Forde; Fergal J O'Brien; Niall F Davis
Journal:  Int Urogynecol J       Date:  2020-11-25       Impact factor: 2.894

3.  LeFort colpocleisis for recurrent pelvic organ prolapse.

Authors:  Xiaojuan Wang; Changdong Hu; Yisong Chen; Keqin Hua
Journal:  Int Urogynecol J       Date:  2019-05-08       Impact factor: 2.894

4.  Mesh complications and failure rates after transvaginal mesh repair compared with abdominal or laparoscopic sacrocolpopexy and to native tissue repair in treating apical prolapse.

Authors:  Vani Dandolu; Megumi Akiyama; Gayle Allenback; Prathamesh Pathak
Journal:  Int Urogynecol J       Date:  2016-08-25       Impact factor: 2.894

Review 5.  Vaginal Mesh Exposure Presentation, Evaluation, and Management.

Authors:  Joao P Zambon; Gopal H Badlani
Journal:  Curr Urol Rep       Date:  2016-09       Impact factor: 3.092

6.  Use and risks of surgical mesh for pelvic organ prolapse surgery in women in New York state: population based cohort study.

Authors:  Bilal Chughtai; Jialin Mao; Jessica Buck; Steven Kaplan; Art Sedrakyan
Journal:  BMJ       Date:  2015-06-02

7.  Preclinical animal study and human clinical trial data of co-electrospun poly(L-lactide-co-caprolactone) and fibrinogen mesh for anterior pelvic floor reconstruction.

Authors:  Xujun Wu; Yuru Wang; Cancan Zhu; Xiaowen Tong; Ming Yang; Li Yang; Zhang Liu; Weihong Huang; Feng Wu; Honghai Zong; Huaifang Li; Hongbing He
Journal:  Int J Nanomedicine       Date:  2016-02-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.